Drs. Hülya Bayır and Robert Clark, Associate Directors at the Safar Center, were recently awarded an R01 grant from the National Institutes of Neurological Disorders and Stroke to fund their study “Mitochondria-Targeted Redox Therapy for Cerebral Ischemia in Developing Brain.” Their research will focus on brain damage after cardiac arrest in infants and children – an important cause of long-term disability. The aim of this multidisciplinary research is to synthesize, develop, and test novel mitochondria-targeting therapeutics toward meaningfully improving neurological outcome and quality of life in infants and children. Dr. Bayır is a Professor in the Department of Critical Care Medicine, Environmental and Occupational Health, and Pediatrics at the University of Pittsburgh. Dr. Robert Clark is a Professor in the Department of Critical Care Medicine and the Chief of Pediatric Critical Care Medicine at the Children’s Hospital of Pittsburgh. Please join us in congratulating them on their success! If you would like to read the full Nature commentary, follow the link.